prices

World News

Biden Administration Takes Aim at High Drug Prices with March-in Rights and Antitrust Initiatives

The Biden administration has announced a two-pronged approach to address high drug prices in the United States, including a new framework for exercising “march-in” rights and initiatives aimed at curbing anti-competitive practices in the healthcare industry. March-in Rights: A New Tool to Lower Drug Costs The administration’s new framework outlines its plans to use “march-in” rights, an existing legal provision…